Overall Technical outlook

Price Summary

2025-09-05, saw SUNPHARMA's stock open at 1582.4, hit a peak of 1599.3, fall to a low of 1575.5, and close higher 0.71% at 1593.6, with 1814149 shares changing hands.
The stock's peak price over the last 52 weeks is 1948.7, with the lowest being 1563.3.
Based on recommendations from 37 analysts, the future price of SUNPHARMA is expected to range from 1525.0 to 2450.0, with an average price expectation around 1941.4054.

Technicals

Support and Resistance: The current price of 1593.6 for SUNPHARMA finds support at 1598.4 and resistance at 1598.4. These levels define a range in which the price might oscillate, with 1598.4 as a potential support and 1598.4 as a resistance level.
SUNPHARMA supportResistance 1b08cf
Support/Resistance for SUNPHARMA


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
SUNPHARMA aroon 1b08cf
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Sun Pharmaceutical Industries Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
SUNPHARMA bbands 1b08cf
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR remains bearish for Sun Pharmaceutical Industries Limited, establishing a crucial resistance level that could hinder any bullish attempts. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult for prices to rise.
SUNPHARMA psar 1b08cf
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
SUNPHARMA stoch 1b08cf
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the slopes of the faster averages hint at a potential reversal. The weakening signals from these shorter-term averages indicate that the current upward momentum may be fading, suggesting that a change in direction could be near.
SUNPHARMA trippleSMA 1b08cf
Tripple SMA chart for Sun Pharmaceutical Industries Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.